Optimizing the Transition to Biosimilars: Considerations for Payers - Episode 7

Integrating Biosimilars for HCPs, into Electronic Health Records, and in Clinical Pathways/Care Plans

Two experts explain if they had to create any incentives for health care providers to prescribe biosimilars, whether they encountered challenges with their electronic health records, and if their biosimilar programs impacted their clinical pathway/care plans.